PulteGroup, Inc.
118.93USD
-1.1400 (-0.95%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $2.65▼ | $2.79 | 1 | 9 |
| Next quarter | $3.28▲ | $3.1 | 11 | 0 |
| Current year | $10.17▲ | $10.02 | 10 | 1 |
| Next year | $11.25▲ | $11.16 | 9 | 2 |
Beat in 2 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $2.36 | $2.48 | +0.12 (+5.3%) |
| 2026-03-31 | $1.81 | $1.79 | -0.02 (-1.1%) |
| 2025-12-31 | $2.83 | $2.56 | -0.27 (-9.5%) |
| 2025-09-30 | $2.9 | $2.96 | +0.06 (+2.1%) |
342 ratings from 41 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| StoneX | Initiated | Buy | $148 | Sep 4, 2026 |
| Wolfe Research | Upgraded from Peer Perform | Outperform | $129 | Aug 24, 2026 |
| Citigroup | Maintained | Neutral | $138 $134 | Jul 24, 2026 |
| RBC Capital | Maintained | Sector Perform | $115 $116 | Jul 23, 2026 |
| Barclays | Maintained | Equal-Weight | $123 $124 | Jul 23, 2026 |
| Evercore ISI Group | Maintained | Outperform | $151 $162 | Jul 23, 2026 |
| Barclays | Maintained | Equal-Weight | $112 $123 | Jul 14, 2026 |
| Wells Fargo | Maintained | Overweight | $140 $150 | Jul 6, 2026 |
| Evercore ISI Group | Maintained | Outperform | $146 $151 | Apr 24, 2026 |
| UBS | Maintained | Buy | $159 $162 | Apr 24, 2026 |
| Wells Fargo | Maintained | Overweight | $132 $140 | Apr 24, 2026 |
| B of A Securities | Maintained | Buy | $145 $140 | Apr 20, 2026 |
| Truist Securities | Maintained | Buy | $170 $150 | Apr 16, 2026 |
| Evercore ISI Group | Upgraded from In-Line | Outperform | $143 $146 | Apr 13, 2026 |
| Wells Fargo | Maintained | Overweight | $150 $132 | Apr 8, 2026 |
| Barclays | Maintained | Equal-Weight | $115 $112 | Apr 8, 2026 |
| Seaport Global | Downgraded from Buy | Sell | $155 $100 | Apr 7, 2026 |
| JP Morgan | Maintained | Overweight | $149 $131 | Feb 3, 2026 |
| Citigroup | Maintained | Neutral | $128 $136 | Feb 3, 2026 |
| RBC Capital | Maintained | Sector Perform | $111 $115 | Jan 30, 2026 |
| Oppenheimer | Reiterated | Outperform | $140 $149 | Jan 30, 2026 |
| Wells Fargo | Maintained | Overweight | $132 $150 | Jan 14, 2026 |
| Citigroup | Maintained | Neutral | $135 $128 | Jan 8, 2026 |
| Citizens | Initiated | Market Outperform | $145 | Jan 7, 2026 |
| UBS | Maintained | Buy | $160 $159 | Jan 6, 2026 |
47 filings from 16 insiders · 7 buy / 2 sell over 6m
Officers and directors of PHM, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| KOART MATTHEW WILLIAMChief Operating Officer | Sell | 7.5k | $120.00 | $895k | May 27, 2026 |
| SNYDER LILADirector | Sell | 3.3k | $117.18 | $391k | May 8, 2026 |
| HAWAUX ANDRE JDirector | Grant | 1.5k | — | — | Apr 29, 2026 |
| GRISE CHERYL WDirector | Grant | 1.5k | — | — | Apr 29, 2026 |
| BLAIR BRYCEDirector | Grantindirect | 1.5k | — | — | Apr 29, 2026 |
| ACTIS-GRANDE KRISTENDirector | Grant | 1.5k | — | — | Apr 29, 2026 |
| SCHALL BENJAMINDirector | Grant | 1.5k | — | — | Apr 29, 2026 |
| GANNON KRISTIN FDirector | Grant | 1.5k | — | — | Apr 29, 2026 |
| SNYDER LILADirector | Grant | 1.5k | — | — | Apr 29, 2026 |
| HENRY KEVIN AOfficer | Sell | 5.2k | $141.04 | $730k | Feb 24, 2026 |
| GANNON KRISTIN FDirector | Grant | 292 | — | — | Feb 10, 2026 |
| O'MEARA BRIEN P.Officer | Sell | 4.0k | $135.51 | $542k | Feb 6, 2026 |
| KOART MATTHEW WILLIAMChief Operating Officer | Sell | 15.3k | $135.79 | $2.08M | Feb 6, 2026 |
| SHELDON TODD NGeneral Counsel | Sell | 14.2k | $135.01 | $1.92M | Feb 6, 2026 |
| MARSHALL RYAN RChief Executive Officer | Gift | 3.8k | — | — | Feb 5, 2026 |
| MARSHALL RYAN RChief Executive Officer | Sell | 111.3k | $133.86 | $14.89M | Feb 5, 2026 |
| FOLLIARD THOMAS JDirector | Sell | 37.0k | $134.04 | $4.96M | Feb 5, 2026 |
| SHELDON TODD NGeneral Counsel | Grant | 20.0k | — | — | Feb 4, 2026 |
| O SHAUGHNESSY ROBERT TOfficer | Grant | 36.9k | — | — | Feb 4, 2026 |
| O'MEARA BRIEN P.Officer | Grant | 5.5k | — | — | Feb 4, 2026 |
No analyst notes on PHM yet.
Analyst Ratings
15 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 2 | 8 | 5 | 1 | 0 | Buy2.31 |
| 1 mo ago | 2 | 7 | 5 | 1 | 0 | Buy2.33 |
| 2 mo ago | 2 | 6 | 6 | 1 | 0 | Buy2.40 |
| 3 mo ago | 2 | 6 | 6 | 1 | 0 | Buy2.40 |